Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $35.8100 (-1.08%) ($35.6800 - $36.8000) on Thu. Feb. 28, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.76% (three month average) | RSI | 46 | Latest Price | $35.8100(-1.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -1.3% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(50%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.38% in a week (0% probabilities). VXX(-13%) UUP(-13%) TLT(-13%) VIXM(-11%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.38% (StdDev 4.76%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
Resistance Level | $38.59 | 5 Day Moving Average | $37.92(-5.56%) | 10 Day Moving Average | $38.65(-7.35%) | 20 Day Moving Average | $38.59(-7.2%) | To recent high | -16.7% | To recent low | 26.1% | Market Cap | $2.661b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |